MedTrace Logo

Long Term Follow Up for CTSN Mitral Valve Repair Studies

NCT03066050 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 368

Last updated 2025-07-16

No results posted yet for this study

Summary

This study is a continuation of two previous studies --- the Severe Ischemic Mitral Regurgitation (SMR) Trial (NCT00807040) and the Moderate Ischemic Mitral regurgitation (MMR) Trial (NCT00806988) --- to learn more about patients' health 5-10 years after their mitral valve surgeries. The investigators will collect long-term health information on SMR and MMR trial participants using electronic medical records, patient and/or family input, public records, and healthcare- and vital status-related databases.

Conditions

Interventions

OTHER

MV Repair

Participants underwent mitral valve repair with annuloplasty and a sub-valvular procedure for severe tethering.

OTHER

MV Replacement

Participants underwent mitral valve replacement and complete preservation of the sub-valvular apparatus.

OTHER

CABG

Participants underwent coronary artery bypass grafting

Sponsors & Collaborators

Principal Investigators

  • Annetine C Gelijns, PhD · Icahn School of Medicine at Mount Sinai

  • Richard Weisel, MD · Toronto General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-03
Primary Completion
2027-07-31
Completion
2027-07-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03066050 on ClinicalTrials.gov